iNova Pharmaceuticals is proud to launch a new anti-inflammatory gel,1 to add to South Africa’s most prescribed muscle relaxant brand, Norflex.

Norflex® Gel, is the first-to-market anti-inflammatory Benzydamine Hydrochloride topical gel in South Africa. It provides patients with a short-term treatment for the symptomatic and topical relief associated with painful inflammatory conditions of the muscloskeletal system. Norflex® Gel will be available in both a 30 g and 75 g pack.

Norflex® Gel can be massaged lightly into the affected area to provide targeted relief between three and six times daily, depending on the severity of the pain1.

Topical, nonsteroidal anti-inflammatory drugs such as Benzydamine Hydrochloride provide effective pain relief in the treatment of acute musculoskeletal conditions, with a lower risk of the systemic adverse events associated with oral NSAIDs1,4.

Patients with traumatic conditions such as sprains, strains, contusions, the after-effects of fractures as well as acute inflammatory conditions such as myalgia and bursitis1,4 will benefit from the triple action effect of Benzydamine Hydrochloride (Norflex® Gel), due to its anti-inflammatory, analgesic and local anaesthetic properties3.

Norflex® Gel is currently available at leading pharmacies.

For more information, go to

  1. Norflex® Gel approved package insert, September 2001.
  2. Impact RX. Script Data – January 2018.
  3. South African Medicine Price Registry. Database of Medicine Prices. [Online] 2018 February 12 [cited 2018 February 15]; Available at URL:
  4. Massey T, et al. Cochrane Database Syst Rev; (6):CD007402. doi:10.1002/14651858.CD007402.pub2.